Clinical Trial Update: Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Examination. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intranasal midazolam to reduce stress and procedural pain during routine retinopathy of prematurity examinations in premature …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: Polish Mother Memorial Hospital Research Institute | Conditions: Drug Safety | Phase 1 | Status: NOT_YET_RECRUITING